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Objective: To evaluate a protocol for selection of placental polyp management, including expectant
management and hysteroscopic resection with or without transarterial embolization (TAE), using power
Doppler color score (PDCS) as the vascularity parameter.
Materials and Methods: This retrospective caseecontrol study included 25 patients who were diagnosed
with placental polyps. We evaluated the vascularity of placental polyps with PDCS measured by
transvaginal ultrasonography as follows: PDCS 1, no blood ﬂow; PDCS 2, minimal ﬂow; PDCS 3, moderate
ﬂow; and PDCS 4, marked blood ﬂow. We then selected expectant management or hysteroscopic
resection with or without TAE.
Results: Three of 17 patients with PDCS 1 or 2 underwent surgical intervention, and expectant
management was successful in 14. Seven of eight patients with PDCS 3 or 4 underwent surgical
intervention, while expectant management was successful in only one patient.
Conclusion: PDCS is a simple examination for evaluating the vascularity of placental polyps. PDCS might
be useful for selecting the optimal treatment for placental polyps, such as expectant management or
surgical intervention, according to their vascularity.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
A placental polyp is a polypoid mass that develops after partu-
rition, induced abortion, and incomplete miscarriage [1,2]. It is a
fragment of retained placental tissue in the uterine cavity that is
synonymous with retained products of conception. The most sig-
niﬁcant of these is a hypervascular placental polypoid mass, which
may be potentially life threatening, as it can cause severe vaginal
hemorrhage that sometimes requires hysterectomy for complete
hemostasis [3,4]. Transarterial embolization (TAE) with hystero-
scopic resection is a minimally invasive procedure for the treat-
ment of hypervascular placental polyps. However, this procedure is
associated with surgical complications such as uterine perforationcs and Gynecology, Nagoya
mai-cho, Showa-ku, Nagoya
wase).
bstetrics & Gynecology. Publishedand infection. Although no standard method to predict severe
spontaneous vaginal hemorrhage due to hypervascular placental
polyps has been established, dilation and curettage without TAE
may be used because it is less invasive [1].
Transvaginal ultrasonography is a convenient and conventional
method for gynecologists, which is widely used to evaluate the
endometrial cavity. Transvaginal Doppler ultrasound has been re-
ported to be useful for the diagnosis and assessment of placental
polyps [5,6]. Hypervascular placental polypoid masses show
prominent vascularity on Doppler ultrasound and computerized
tomographic angiography [2,7]. Therefore, insufﬁciently assessed
dilation and curettage can lead to life-threatening hemorrhage. TAE
followed by hysteroscopic resection has recently been reported as a
useful procedure [3,4,7]. In cases of hypovascular placental polyps
that do not require therapeutic intervention, expectant manage-
ment has been reported as a curative treatment [1].
In this study, we retrospectively reviewed 25 placental polyp
cases and assessed the validity of surgical interventionwith respect
to vascularity evaluated with Doppler ultrasound.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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Twenty-ﬁve patients with placental polyps treated at Nagoya
University Hospital, Nagoya, Japan between January 2008 and
February 2013were included in this study. This studywas approved
by the Ethics Committee of Nagoya University Graduate School of
Medicine. The diagnosis of placental polyps was based on the
presence of a measurable focus of hyperechoic mass within the
endometrial cavity on two-dimensional gray-scale transvaginal
ultrasound. The diagnosis was conﬁrmed by hysteroscopy and/or
magnetic resonance imaging with or without blood ﬂow on
transvaginal ultrasound.
The International Ovarian Tumor Analysis group has suggested
the use of subjective semiquantitative assessment of ﬂow to
describe the vascular features of ovarian masses [8,9]. A color score
is used to describe the amount of blood ﬂow for the whole tumor:
color score 1, no detectable blood ﬂow; score 2, minimal ﬂow; score
3, moderate ﬂow; and score 4, highly vascular [5,8,9]. We divided
the 25 patients into four groups based on the power Doppler color
score (PDCS; Figure 1). The transvaginal ultrasound settings were
adjusted to allow maximal sensitivity to blood ﬂow. Ultrasonic
frequency was set at 8.0 MHz and power Doppler gainwas reduced
until the artifacts disappeared. This color score only refers to the
color Doppler image, not the Doppler shift spectrum. A subjective
qualitative assessment of ﬂow within the placental polyp was
performed.
We also evaluated the patients' ages, serum b-human chorionic
gonadotropin (b-hCG) levels, serum hemoglobin (Hb) concentra-
tions, maximum diameter of placental polyps on initial medical
examination, and treatment periods. Patients who received
expectant management were included as controls and those who
underwent hysteroscopic resection only or TAE followed by hys-
teroscopic resection were included as cases. Some patients under-
went computed tomography (CT) and three-dimensional CT
angiography for hypervascularity evaluation.Figure 1. Power Doppler color score (PDCS) as the vascularity parameter of placental polyps.
ﬂow), and (D) PDCS 4 (highly vascular).Data were analyzed using IBM SPSS Statistics version 20 (IBM,
Endicott, NY, USA). We used the Student t test or the Man-
neWhitney U test to compare the patients' characteristics, vari-
ables, serum b-hCG levels, serum Hb levels, maximum placental
polyp diameter, and treatment periods between cases and controls.
The ManneWhitney U test was applied instead of the Student t test
when the variables did not pass a normality test. A p value < 0.05
was considered statistically signiﬁcant.
Results
Twenty-ﬁve women with a median age of 32 years (range,
22e42 years) were recruited for this study. Table 1 presents the
patients' clinical characteristics, including PDCS. The median
(minimumemaximum) serum b-hCG levels, Hb levels, and treat-
ment periods of the 25 patients were 20.0 mIU/mL (range,
1.2e4377.3 mIU/mL), 11.9 g/dL (range, 4.9e14.3 g/dL), and 45 days
(range, 3e202 days), respectively. The mean maximum placental
polyp diameter was 22 mm (range, 10e45 mm). Two women un-
derwent hysteroscopic resection alone, eight women underwent
TAE followed by hysteroscopic resection, and 15 women received
expectant management. Of the 25 patients, 28% (7/25) had PDCS 1,
40% (10/25) had PDCS 2, 24% (6/25) had PDCS 3, and 8% (2/25) had
PDCS 4. One of 17 women with PDCS 1 or 2 underwent hystero-
scopic resection, two underwent TAE followed by hysteroscopic
resection, and 14 received expectant management. The two pa-
tients with TAE followed by hysteroscopic resection had undergone
dilation and curettage before transfer to our hospital. One of eight
women with PDCS 3 or 4 underwent hysteroscopic resection, six
underwent TAE followed by hysteroscopic resection, and one with
PDCS 4 received expectant management. Chi-square test of inde-
pendence showed that increasing PDCS was related to difﬁculty in
successful expectant management (c2 ¼ 11.06; p ¼ 0.002; Table 2).
Figure 2 shows the ﬁndings of a patient with PDCS 4 (Case 22 in
Table 1) on transvaginal Doppler ultrasound at initial medical(A) PDCS 1 (no detectable blood ﬂow), (B) PDCS 2 (minimal ﬂow), (C) PDCS 3 (moderate
Table 1
Patients' clinical characteristics.
Case Age (y) Gravida Para NVD CS Miscarriage Artiﬁcial
abortion
b-hCG
(mIU/mL)
Hb Diameter
(mm)
PDCS Procedure Treatment
perioda
1 32 4 0 0 0 4 0 3.9 10.7 30 3 TAE followed by hysteroscopic
resection
21
2 32 3 0 0 0 3 0 1082.0 7.5 40 3 TAE followed by hysteroscopic
resection
16
3 29 4 2 0 0 0 0 1.4 11.0 15 2 Expectant management 30
4 41 2 1 1 1 1 0 114.0 11.0 40 3 TAE followed by hysteroscopic
resection
53
5 39 1 1 1 0 0 0 <1.2 13.2 15 1 Expectant management 60
6 29 1 0 0 1 1 0 32.3 13.2 10 2 Expectant management 25
7 27 2 1 0 1 1 0 134.0 13.2 10 2 Expectant management 87
8 25 2 1 0 1 1 0 4.5 13.0 15 1 Expectant management 51
9 35 3 0 0 0 3 0 83.6 12.1 40 3 Hysteroscopic resection 38
10 29 1 0 0 0 1 0 20.0 11.9 20 2 Hysteroscopic resection 25
11 40 1 1 1 0 0 0 <1.2 13.2 15 1 Expectant management 158
12 39 2 1 1 0 1 0 <1.2 14.3 20 1 Expectant management 49
13 37 5 3 0 3 2 0 34.5 11.8 45 2 Expectant management 92
14 26 1 0 0 0 0 1 9.8 10.6 35 3 TAE followed by hysteroscopic
resection
6
15 42 2 1 1 0 1 0 112.0 12.1 18 2 Expectant management 74
16 38 2 1 0 1 1 0 <1.2 12.0 20 1 Expectant management 31
17 29 1 0 0 0 1 0 14.4 8.0 28 1 Expectant management 45
18 32 1 1 0 1 0 0 18.9 12.3 30 2 Expectant management 106
19 35 3 0 0 0 1 2 113.1 12.2 22 4 TAE followed by hysteroscopic
resection
5
20 29 2 2 1 1 0 0 25.8 11.3 44 3 TAE followed by hysteroscopic
resection
3
21 32 3 2 0 2 1 0 <1.2 11.7 32 2 Expectant management 202
22 29 1 0 0 0 0 1 351.2 12.5 34 4 Expectant management 99
23 25 3 1 1 0 2 0 35.7 4.9 21 2 TAE followed by hysteroscopic
resection
5
24 22 3 1 0 1 1 1 9.4 8.7 14 1 Expectant management 28
25 36 3 1 0 1 2 0 4377.3 11.0 26 2 TAE followed by hysteroscopic
resectionb
69
Median
(range)
32 (22e42) 20.0
(1.2e4377.3)
11.9
(4.9e14.3)
22
(10e45)
45
(3e202)
CS ¼ cesarean section; Hb ¼ hemoglobin; NVD ¼ normal vaginal delivery; PDCS ¼ power Doppler color score; TAE ¼ transarterial embolization; b-hCG ¼ b-human chorionic
gonadotropin.
a The days that were about to conﬁrm the disappearance of placental polyps from the ﬁrst medical examination.
b The case of expectant management failure.
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three-dimensional CT angiography, and transvaginal Doppler ul-
trasound after elimination of the placental polyp.
Subsequently, we compared each parameter between the cases
and controls (Table 3). We found no signiﬁcant difference in ages
between the cases and controls (p ¼ 0.799). By contrast, we found
signiﬁcant differences in b-hCG levels (p ¼ 0.030), Hb concentra-
tions (p ¼ 0.013), maximum placental polyp diameter (p ¼ 0.016),
PDCS (p ¼ 0.001), and the treatment periods (p ¼ 0.002) measured
between the cases and controls.
Discussion
A portion of placental tissue may become rigidly attached to the
uterine muscle layer and develop into a hypervascular placental
polyp by tissue degeneration with ﬁbrin deposition and inﬂam-
matory changes [2,3]. Retained placental tissue is suspected inTable 2
Procedures used according to PDCS.*
Procedure PDCS 1 & 2 (n ¼ 17) PDCS 3 & 4 (n ¼ 8)
Hysteroscopic resection
with or without TAE
3 7
Expectant management 14 1
* p ¼ 0.002 (Chi-square test).
PDCS ¼ power Doppler color score; TAE ¼ transarterial embolization.cases of persistent postpartum or postabortion bleeding. The inci-
dence of placental polyp is < 0.25% of all pregnancies. Furthermore,
only 6% of placental polyps are hypervascular and cause severe
hemorrhage [3,10].
Selection of an appropriate management strategy for placental
polyps is important because they may cause severe hemorrhage,
which could be potentially life threatening and require hysterec-
tomy [3,4]. Hysterectomy is not an option for patients hoping to
preserve fertility. Therefore, TAE followed by hysteroscopic resec-
tion could be used for hypervascular placental polyps instead of
hysterectomy. However, TAE has been associated with complica-
tions such as uterine necrosis and placenta accreta in subsequent
pregnancy [11,12].
Transvaginal Doppler ultrasound is a useful initial test for a
suspected hypervascular uterine lesion. In addition, more speciﬁc
imaging modalities for the diagnosis of placental polyps include CT
angiography and magnetic resonance imaging [3,4,7,13]. However,
there are no reliable indexes to predict severe hemorrhage and the
feasibility of expectant management.
In this study, we demonstrated that evaluation of PDCS in the
initial examination was helpful for predicting the prognosis of
placental polyps. According to our results, PDCS 1 and 2 indicate
low risk and PDCS 3 and 4 indicate high risk of severe hemorrhage.
Speciﬁcally, TAE followed by hysteroscopic resection should be
performed in high-risk cases, and we recommend expectant
management for low-risk cases (Figure 3). We successfully per-
formed expectant management for all patients with PDCS 1. Among
Figure 2. Preoperative and postoperative images of a patient with Power Doppler color score 4. (A) Doppler ultrasound on initial medical examination, (B) early arterial phase of
dynamic contrast-enhanced computed tomography, (C) three-dimensional computed tomography angiography, and (D) transvaginal Doppler ultrasound after elimination of the
placental polyp.
Table 3
Difference in variables between cases and controls.
Variable Cases (n ¼ 10) Controls (n ¼ 15) p
Age (y) 32.0 ± 4.9 32.6 ± 6.1 0.799
b-hCG (mIU/mL) 59.7 (3.9e4377.3) 9.4 (1.2e351.0) 0.030
Hb (g/dL) 11.0 (4.9e12.2) 12.3 (8.7e14.3) 0.013
Diameter (mm) 31.8 ± 9.1 21.4 ± 10.1 0.016
PDCS 3 (2e4) 2 (1e4) 0.001
Treatment period (d) 18.5 (3e69) 60 (25e202) 0.002
Data are presented as mean ± standard deviation or median (mini-
mumemaximum).
Hb ¼ hemoglobin; PDCS ¼ power Doppler color score; b-hCG ¼ b-human chorionic
gonadotropin.
Figure 3. Algorithm showing the management of placental polyps using power
Doppler color score (PDCS). TAE ¼ transarterial embolization; TCR ¼ transcervical
resection.
M. Mori et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 534e538 537patients with PDCS 2, one underwent hysteroscopic resection and
two underwent TAE followed by hysteroscopic resection. Two of
these patients had undergone dilation and curettage before our
initial medical examination. In these cases, hypervascularity of
placental polyps might not have been evaluated correctly using
PDCS just after curettage. However, expectant management was
not successful in one patient with PDCS 2 (Case 25 in Table 1). This
patient had the highest b-hCG level in this study group. Viability of
the retained placental tissue might have been related to hemor-
rhage requiring TAE.
By contrast, hypervascularity in PDCS 3 or 4 cases demonstrates
persistent communication between the residual placental tissues
and maternal circulation. Therefore, spontaneous elimination of
placental polyps without severe hemorrhage is unlikely. Thus,
hysteroscopic resection or TAE followed by hysteroscopic resection
was performed for seven of eight caseswith PDCS 3 and 4. However,
expectant management was successfully performed in one patient
with PDCS 4 (Case 22 inTable 1); thus, surgical interventionmaynot
be necessary for some patients with PDCS 3 and 4. Therefore, pro-
spective studies are needed to evaluate the use of PDCS as a pre-
dictor of successful expectant management for placental polyps.Another problem to be addressed is the treatment period.
Although expectant management is the most minimally invasive
procedure for patients, the treatment duration could be longer than
that of surgical intervention. We encountered three cases of
expectant management performed for over 100 days. Hystero-
scopic resection without TAE after a certain period of expectant
management in cases with PDCS 1 and 2 might be a preferable
strategy.
In conclusion, an appropriate management strategy for
placental polyps is important, and insufﬁciently assessed dilation
and curettage for hypervascular placental polyps should be avoi-
ded. PDCS is a simple variable for evaluating the vascularity of
placental polyps. We recommend expectant management for cases
of placental polyps with PDCS 1 and 2, and surgical intervention, if
needed, after TAE in cases of PDCS 3 and 4. This is the ﬁrst report of
a therapeutic algorithm for placental polyps.
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